The role of the inflammatory microenvironment in Acellular Nerve Allografts (ANAs) repairing nerve gaps
炎症微环境在无细胞神经同种异体移植物(ANA)修复神经间隙中的作用
基本信息
- 批准号:10678384
- 负责人:
- 金额:$ 3.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAllogenicAllograftingAutologous TransplantationAxonBiomedical EngineeringBlood VesselsCaringCellsChemicalsChronicClinicClinicalDataDefectDetergentsExpenditureExtracellular MatrixFK506FellowshipGene ExpressionGoalsHarvestImmunologyImmunosuppressive AgentsInflammationInflammatoryInflammatory ResponseInjuryInterventionKnowledgeLearningLengthMacrophageMeasuresModelingModificationMolecular TargetMorbidity - disease rateMorphologyNatural regenerationNerveNerve RegenerationNeurobiologyOperative Surgical ProceduresPatientsPeripheral NervesPeripheral nerve injuryProcessQuality of lifeRattusRecovery of FunctionResearchRoleScientistSiteT-LymphocyteTacrolimusTechniquesTestingTimeTrainingTranslatingTraumaUnited Statesangiogenesisaxon regenerationcell motilitycytokineexperienceimmunogenicityinflammatory markerinflammatory milieuinflammatory modulationmigrationmyelinationnerve autograftnerve damagenerve gapnerve injurynerve repairnovelpharmacologicreconstructionregeneration potentialregenerativerepairedsciatic nervesingle-cell RNA sequencingstandard of caretherapy development
项目摘要
PROJECT SUMMARY/ABSTRACT
Reconstruction of peripheral nerve gap injuries continues to pose a challenge in the clinic due to their
significant long-term functional morbidity. Multiple surgical approaches have been developed to promote
nerve regeneration across a damaged nerve with a gap. In the clinic, nerve autografts are considered the
standard of care in treating nerve gaps due to their superior capacity in promoting nerve regeneration.
However, the use of nerve autografts is limited by their availability, increased surgery time, loss of nerve
function from the lost nerve and donor site morbidity. Acellular nerve allografts (ANAs) have been proposed
as a clinical alternative to autografts in repairing nerve gaps due to their capability in promoting regeneration
across short gaps (< 3 cm). ANAs are allogenic nerves that are chemically processed to remove the cells,
reducing immunogenicity, while maintaining the extracellular matrix (ECM) that will allow cell migration into
the ANA and subsequent nerve regeneration. However, unlike autografts, ANAs do not support regeneration
across long defects (> 3 cm). The reason why long ANAs do not promote regeneration or regenerate poorly
is not completely understood. Previous studies have demonstrated the critical role of inflammatory cells,
such as macrophages and T cells, in regulating and promoting the early stages of nerve regeneration in
ANAs (before 4 weeks post-surgery). Specifically, macrophages will promote angiogenesis and T cells will
promote axonal myelination. However, when compared to short ANAs capable of robust regeneration,
preliminary data shows an increase in the expression of pro-inflammatory cytokines and changes in the
morphology of blood vessels in long ANAs at the later stages of nerve regeneration (between 4- and 8-
weeks post-surgery). The increase in the expression of pro-inflammatory cytokines and the changes in the
morphology of blood vessels happen after angiogenesis has occurred and axons have started migrating into
the ANAs. These changes suggest that a pro-inflammatory environment develops inside long ANAs in the
later stages of nerve regeneration, and this correlates with changes in the morphology of blood vessels and
a decrease in the number of myelinated axons. We hypothesize the state of chronic inflammation in long
ANAs is disrupting the regenerative microenvironment in long ANAs. In brief, the proposed research aims
to characterize and compare the inflammatory microenvironment that develops in the later stages of nerve
regeneration in long ANAs with the microenvironment in the regenerated short ANAs and autografts. This
project also explores the effect of reducing inflammation in long ANAs, using a pharmacological intervention,
on axonal regeneration. An integral part of this study is to identify the cell subpopulations promoting the pro-
inflammatory microenvironment in long ANAs. An in-depth analysis of these cell subpopulations may provide
specific molecular targets used to develop therapies aimed to promote nerve regeneration in long ANAs.
项目摘要/摘要
外围神经间隙损伤的重建继续在诊所构成挑战
显着的长期功能发病。已经开发了多种手术方法来促进
神经在受损神经上的神经再生有间隙。在诊所中,神经自体移植被认为
由于其在促进神经再生方面的较高能力,治疗神经间隙的护理标准。
但是,神经自体的使用受到其可用性的限制,手术时间增加,神经损失
失去神经和供体部位发病的功能。已经提出了细胞神经同种异体移植物(ANA)
作为自体移植修复神经间隙的临床替代方案,由于其能力促进再生
在短间隙(<3厘米)中。 ANA是同性神经,对去除细胞的化学处理,
降低免疫原性,同时保持细胞外基质(ECM),这将允许细胞迁移到
ANA和随后的神经再生。但是,与自体移植不同,ANA不支持再生
跨长缺陷(> 3厘米)。长期ANA不促进再生或再生较差的原因
不完全理解。先前的研究表明炎性细胞的关键作用,
例如巨噬细胞和T细胞,在调节和促进神经再生的早期阶段
ANA(手术后4周之前)。具体而言,巨噬细胞将促进血管生成,T细胞将
促进轴突髓鞘。但是,与能够强大再生的短ANA相比
初步数据表明,促炎细胞因子的表达增加以及变化
在神经再生的后期长ANA中的血管形态(4-至8-之间
手术后几周)。促炎细胞因子表达的增加以及
血管的形态发生在发生血管生成后发生,轴突开始迁移到
阿纳斯。这些变化表明,促炎的环境在长期的ANA中发展
神经再生的后期阶段,这与血管形态的变化和
骨髓轴突的数量减少。我们假设长时间的慢性炎症状态
Anas正在破坏长期ANA的再生微环境。简而言之,拟议的研究目的
表征和比较在神经后期发展的炎症微环境
在长期anas中再生,并在重生的短ANA和自体移植物中进行微环境。这
项目还探讨了使用药理干预措施减少长ANA炎症的效果,
关于轴突再生。这项研究的组成部分是确定促进促进的细胞亚群
长期ANA的炎症微环境。对这些细胞亚群的深入分析可能会提供
用于开发旨在促进长期ANA神经再生的疗法的特定分子靶标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jesús Alberto Acevedo Cintrón其他文献
Jesús Alberto Acevedo Cintrón的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
肿瘤球混合堆砌-诱导分化构建同源性血管化结肠癌类器官用于血管发生干预靶点筛选
- 批准号:82373453
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
非小细胞肺癌中靶向抑制同源性重组修复增敏免疫检查点抑制剂疗效的研究和机制探索
- 批准号:82103045
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
非小细胞肺癌中靶向抑制同源性重组修复增敏免疫检查点抑制剂疗效的研究和机制探索
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FHF2对肥厚心肌钙致钙释放的影响及其机制研究
- 批准号:81900249
- 批准年份:2019
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
PTEN通过激活细胞程序性坏死通路促进APP淀粉样蛋白代谢的机制研究
- 批准号:81901116
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
相似海外基金
Targeting innate immunity for induction of robust renal allograft tolerance
针对先天免疫诱导强大的肾同种异体移植耐受
- 批准号:
10622050 - 财政年份:2023
- 资助金额:
$ 3.36万 - 项目类别:
Allograft inflammatory factor-1 and immune tolerance
同种异体移植物炎症因子-1和免疫耐受
- 批准号:
10511362 - 财政年份:2022
- 资助金额:
$ 3.36万 - 项目类别:
Immuno-Isolating capsule for delivery of cell-based therapy for restoration of ovarian endocrine function in an animal model
免疫隔离胶囊用于在动物模型中提供基于细胞的治疗以恢复卵巢内分泌功能
- 批准号:
10677892 - 财政年份:2022
- 资助金额:
$ 3.36万 - 项目类别:
Graft extracellular vesicles as promoters of anti-donor immunity in cardiac and skin transplantation
移植细胞外囊泡作为心脏和皮肤移植中抗供体免疫的促进剂
- 批准号:
10707137 - 财政年份:2022
- 资助金额:
$ 3.36万 - 项目类别:
Graft extracellular vesicles as promoters of anti-donor immunity in cardiac and skin transplantation
移植细胞外囊泡作为心脏和皮肤移植中抗供体免疫的促进剂
- 批准号:
10560271 - 财政年份:2022
- 资助金额:
$ 3.36万 - 项目类别: